Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--response

Clin Cancer Res. 2013 Oct 1;19(19):5542. doi: 10.1158/1078-0432.CCR-13-2234. Epub 2013 Sep 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • B7-H1 Antigen / antagonists & inhibitors*
  • Humans
  • Neoplasms / therapy*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • Programmed Cell Death 1 Receptor